| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |